The likelihood of BCS + RT decreased if patients were diagnosed during 2000–2004, detected symptomatically, had tumour sizes ≥ 20–≤50 mm, negative/unknown oestrogen and progesterone receptor status, unknown grade and with increasing lymph node involvement. Here, PGR is linked to neoplasm.